Investigative Site — Tampa, Florida

Public research footprint of Investigative Site, compiled from the ClinicalTrials.gov public registry.

268

Registered studies

Active

Recruiting now

178

Completed

Stopped or withdrawn

Most-studied conditions

Hidradenitis Suppurativa · Systemic Lupus Erythematosus · Primary Prevention of Atherosclerotic Cardiovascular Disease · Advanced NRAS/BRAFT wt Cutaneous Melanoma

Recently updated registry entries

NCT06136741 — A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult… (Active Not Recruiting)
NCT06667076 — A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… (Recruiting)
NCT07543120 — An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Investigative Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.